← Back
$PRME All transactions

Prime Medicine, Inc.

▲ BUY 10b5-1 Plan
4 / 10

Conviction

$ Value

$53K

Shares

21,000

Price

$3

Filed

Jul 1

Why this score? (4/10)
  • Open market buy (+3)
  • 10%+ owner (+1)

Insider

Name

Liu David R.

Title

CIK

0001664439

Roles

10% Owner

Transaction Details

Transaction Date

2025-06-30

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,240,945

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. | The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.44 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001628280-25-033754

Form Type

4

Issuer CIK

0001894562

Liu David R.'s History

Date Ticker Type Value
2025-06-30 PRME $53K
2025-06-23 PRME $45K
2025-06-16 PRME $31K
2025-06-11 PRME $34K

Other Insiders at PRME (90d)

Insider Bought Sold Last
Makhni Svetlana Ni
Chief Financial Officer
2026-04-16